Myriad Genetics (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Myriad Genetics's Discounted Cash Flow analysis, Myriad Genetics's Warren Buffet analysis, and Myriad Genetics's Weighted Average Cost of Capital (WACC) Analysis. Notes on the Comparative Multiple Analysis of Myriad GeneticsWikiWealth compares Myriad Genetics's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Myriad Genetics's comparative analysis. Notes from the analysis: 1. WikiWealth uses quantitative measures to determine the multiple range for Myriad Genetics. Helpful Information for Myriad Genetics's AnalysisHow does this work? The Comparative Investment Analysis determines the value of Myriad Genetics by comparing Myriad Genetics financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups. Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Myriad Genetics. See the Myriad Genetics cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Myriad Genetics. Also, see the Myriad Genetics's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Myriad Genetics's valuation conclusion for a quick summary. |
|